Medifast, Inc.
MED
$12.72
-$0.40-3.05%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -196.38% | -28.93% | 113.82% | -198.04% | 37.80% |
| Total Depreciation and Amortization | -73.49% | 306.39% | -295.50% | -5.95% | -2.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 120.12% | -203.78% | -33.31% | 2,395.31% | -92.63% |
| Change in Net Operating Assets | 63.76% | -514.27% | 219.61% | 80.56% | 45.41% |
| Cash from Operations | 168.85% | -154.53% | -30.58% | 79.47% | -30.79% |
| Capital Expenditure | 33.39% | -64.39% | 28.28% | -5.27% | -94.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.90% | -4,273.98% | 34.01% | 36.40% | 90.45% |
| Cash from Investing | 89.43% | -990.40% | 29.62% | 8.76% | 74.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -56.63% |
| Repurchase of Common Stock | -36,800.00% | 50.00% | 87.50% | 98.04% | -8,070.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | 75.00% | 99.44% | 96.05% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -56,200.00% | 66.67% | 85.00% | 98.66% | 91.67% |
| Foreign Exchange rate Adjustments | -- | -100.00% | -85.71% | 86.67% | 107.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.24% | -434.37% | -30.86% | 247.90% | 116.55% |